Estudo de síntese e estabilidades química e enzimática de fármaco dirigido dendrimérico potencialmente ativo em doença de Chagas / Synthesis, chemical and enzymatic stability studies of targeted dendrimer potentially active in Chagas disease

A doença de Chagas representa um problema de saúde pública em muitos países e regiões. O tratamento consiste em fármacos tóxicos, com eficácia discutível, principalmente, na fase crônica da doença. Assim, faz-se necessário o planejamento de novos quimioterápicos, mais seguros e eficazes. Os dendrímeros são novas arquiteturas moleculares formadas por um foco central e ramificações partindo desse foco. Apresentam diversas aplicações biológicas como, por exemplo, atuar como transportadores de fármacos. Face ao exposto, o objetivo deste trabalho foi o estudo de condições para ligar o ácido anacárdico (AA) em derivado dendrimérico com potencial ação na doença de Chagas, o qual tem como foco central o ácido succínico (AS) e ramificações compostas por arginina (Arg) e lisina (Lys). Sabe-se que a cruzaína, uma cisteíno-protease do T. cruzi, catalisa a hidrólise de ligação peptídica entre lisina e arginina. A síntese dos compostos em fase sólida forneceu os derivados brutos: (1) pró-fármaco AA-K-R-NH2 e (2) G.05 AA-K(AS)-R-NH2, que foram purificados e caracterizados por Cromatografia Líquida de Alta Eficiência e espectrometria de massas. Os compostos purificados AA-K-R-NH2 e AA-K(AS)-R-NH2 apresentaram rendimentos de 34% e 47%, com pureza de 88% e 98%, respectivamente. Os resultados dos experimentos enzimáticos utilizando o AA-K-R-NH2 não foram conclusivos. Acredita-se que a baixa solubilidade e/ou baixa concentração podem ter contribuído para tal. Já na estabilidade química em pH 7,4 (que simula pH sanguíneo), pH 1,2 (que simula pH estomacal) e pH 8,5 (que simula pH intestinal), observou-se que o AA-K(AS)-R-NH2 foi estável durante as 24 h de ensaio. Estes últimos resultados são interessantes, pois espera-se que o pró-fármaco dendrimérico alcance o T. cruzi estruturalmente integro, sofrendo hidrólise e liberação do composto ativo no interior do parasita

Chagas disease is a public health problem in many countries and regions. The treatment consists of toxic drugs, with debatable efficacy, mainly, in the chronic phase of the disease. Thus, it is necessary to plan new chemotherapeutics, safer and more effective than those drugs. Dendrimers are new molecular architectures composed by a central focus and branching from that focus. They present several biological applications, such as acting as drug carriers. Thereby, the goal of this work was the study of conditions to bind anacardic acid (AA) in a dendrimeric derivative with potential action in Chagas disease, which was composed by a central focus of succinic acid (AS) and branches of arginine (Arg) and lysine (Lys). Cruzain, a T. cruzi cysteine protease, is known to catalyze the peptide-binding hydrolysis between lysine and arginine. Synthesis of the solid phase compounds provided the crude derivatives: (1) prodrug AA-KR-NH2 and (2) G.05 AA-K(AS)-R-NH2, which were purified and characterized by High Performance Liquid Chromatography (HPLC) and mass spectrometry. The purified AA-K-R-NH2 and AA-K(AS)-R-NH2 compounds showed yields of 34% and 47%, with purity of 88% and 98% respectively. The results of the enzymatic experiments using AA-K-R-NH2 were not conclusive. It is believed that the low solubility and/or low concentration may have contributed for this. On the chemical stability at pH 7.4 (which simulates blood pH), pH 1.2 (which simulates stomach pH) and pH 8.5 (which simulates intestinal pH), it was observed that AA-K(AS)R-NH2 was stable for 24 hours. These latter results are interesting because the dendrimeric prodrug is expected to reach structurally integral T. cruzi, undergoing hydrolysis and release of the active compound within the parasite

Effect of anacardic acid, a Hsp90 inhibitor, on proliferation, invasion and migration of breast cancer MDA-MB-231 cells / 南方医科大学学报

<p><b>OBJECTIVE</b>To explore the effect of the Hsp90 inhibitor anacardic acid on cell proliferation, invasion and migration of breast cancer MDA-MB-231 cells.</p><p><b>METHODS</b>The inhibitory effect of anacardic acid on Hsp90 was assessed with in vitro ATPase inhibition assay and ATP-sepharose binding assay. MTT assay was used to detect the growth inhibition induced by anacardic acid in MDA-MB-231 cells. Transwell assays were used to evaluate MDA-MB-231 cell invasion and migration. Western blotting was performed to assess the effect of anacardic acid in triggering the degradation of MMP-9, TIMP-1, Hsp90, and Hsp70.</p><p><b>RESULTS</b>Anacardic acid exhibited a modest activity of ATPase inhibition with an IC50 value of 82.5 µmol/L. Anacardic acid significantly suppressed the proliferation of MDA-MB-231 cells in a dose-dependent manner (IC50 value of 29.3 µmol/L). Treatment with 12.5, 25, and 50 µmol/L anacardic acid for 36 h caused inhibition of cell invasion by 23.6%, 56.6%, and 67.0% in MDA-MB-231 cells, respectively (P<0.05), and anacardic acid treatment for 24 h inhibited the cell migration by 30.0%, 45.5%, and 77.5%, respectively (P<0.05). Anacardic acid dose-dependently induced MMP-9 degradation, but did not obviously affect Hsp90 or Hsp70 expressions.</p><p><b>CONCLUSION</b>Anacardic acid can significantly inhibit the proliferation, invasion, and migration of MDA-MB-231 cells, the mechanism of which may involve the inhibition of Hsp90 ATPse activity and down-regulation of MMP-9 expression.</p>

Efeitos dos ácidos anacárdicos no sistema respiratório de camundongos submetidos à instilação intranasal de partículas resultantes da combustão de diesel / Effects of the anacardic acids in the respiratory system of mice after intranasal instillation of diesel exhaust particles

Os ácidos anacárdicos (AAs) provenientes do líquido da casca da castanha de caju têm propriedades antioxidantes e anti-inflamatórias. Seus efeitos são bem estabelecidos em vários sistemas in vitro, no entanto não há publicações a respeito de suas ações no tecido pulmonar. No presente estudo, foram analisados os efeitos da suplementação dos AAs em modelo de inflamação subaguda induzida pelas partículas resultantes da combustão do diesel (DEP) em camundongos. Camundongos BALB/c machos receberam por 20 dias consecutivos instilação intranasal de 50 g DEP diluídos em 10 L de salina. Como pré-tratamento, 10 dias antes do ínicio da instilação intranasal com DEP, os animais foram tratados por via oral com 50, 150 ou 250 mg/kg de AAs diluídos em 100 L de óleo da castanha de caju ou apenas 100 L de óleo da castanha de caju (veículo). Foram analisados: a densidade de células inflamatórias, as células imunomarcadas para TNF-, NF-B e KC e a área imunomarcada para 8-isoprostano no parênquima pulmonar. Além disso, foi mensurado o perfil celular e de citocinas no LBA e a área imunomarcada por VCAM e KC nos vasos peribronquiolares. As atividades das enzimas antioxidantes GR, GPx, GST e CAT foram analisadas no tecido pulmonar e no sangue periférico. O tratamento com os AAs foram capazes de agir como substâncias protetoras no parênquima pulmonar. A dose de 50 mg/kg demonstrou efeitos mais proeminentes na redução dos marcadores de inflamação pulmonar, no entanto as três doses foram capazes de atuarem como substâncias antioxidantes aumentando a atividade das enzimas antioxidantes e reduzindo a expressão de VCAM nos vasos pulmonares na presença da sobrecarga oxidativa induzida pelas DEP. Portanto, os AAs demonstraram ter potencial preventivo contra os efeitos das DEP no sistema respiratório, atuando como substâncias naturais com propriedades anti-inflamatórias e antioxidantes.

Anacardic acids (AAs) from cashew nut shell liquid have important antioxidant properties. However despite their well established effects in several systems in vitro, there were no reports about their effects in lung tissue. In this present study, we examined the effects of AAs supplementation in a model of low diesel exhaust particles (DEP) induced lung inflammation in mice. Male BALB/c mice received intranasal instillation of 50 g DEP diluted in 10 L of saline solution during 20 days. Ten days before instillation, animals were oral treated by the following 30 days with 50, 150 or 250 mg/Kg AAs diluted in 100 L of cashew nut oil (CNO) or vehicle (100 L of CNO). In order to evaluate anti-inflammatory and antioxidant effects, we analyzed the influx of inflammatory cells, TNF-, NF-B and KC positive cells; and the expression of 8-isoprostane in alveolar parenchyma. In addition, we measured the cellular profile and cytokines level in BALF and the VCAM and KC expressions in peribronchiolar pulmonary vessels.The activities of antioxidant enzymes GR, GPx, GST and CAT were analyzed by spectrophotometric method to assessing oxidative status in the lung tissue and in the peripheral blood. Treatment with AAs was able to act as a protective substance in lung tissue. The dose of 50 mg/kg showed more prominent effects in decreasing the inflammatory markers caused by DEP, however all the three doses are able to preserve antioxidant enzymes activities in the presence of oxidative charge and decreased the expression of VCAM in vessels. Furthermore, we demonstrated that AAs, which are natural substance, have potential effects against air pollution-related effects in respiratory system, acting as anti-inflammatory and antioxidant properties.